Radiology and Oncology (Jul 2020)

Consolidation radiotherapy for patients with extended disease small cell lung cancer in a single tertiary institution: impact of dose and perspectives in the era of immunotherapy

  • Stanic Karmen,
  • Vrankar Martina,
  • But-Hadzic Jasna

DOI
https://doi.org/10.2478/raon-2020-0046
Journal volume & issue
Vol. 54, no. 3
pp. 353 – 363

Abstract

Read online

Consolidation radiotherapy (cRT) in extended disease small cell lung cancer (ED-SCLC) showed improved 2-year overall survival in patients who responded to chemotherapy (ChT) in CREST trial, however results of two meta - analysis were contradictive. Recently, immunotherapy was introduced to the treatment of ED-SCLC, making the role of cRT even more unclear. The aim of our study was to access if consolidation thoracic irradiation improves survival of ED-SCLC patients treated in a routine clinical practice and to study the impact of cRT dose on survival. We also discuss the future role of cRT in the era of immunotherapy.

Keywords